UPI

Kcentra approved for the urgent reversal of vitamin K

WASHINGTON, April 30 (UPI) -- The U.S. Food and Drug Administration approved Kcentra for the urgent reversal of vitamin K antagonist anti-coagulation in adults with acute major bleeding. "The FDA's ...
Medindia

Kcentra®, from CSL Behring, Receives FDA Approval for Use in Warfarin Reversal in Patients Undergoing Surgery

CSL Behring today announced that Kcentra ® (Prothrombin Complex Concentrate [Human]) has received U.S. Food and Drug Administration (FDA) approval for an expanded indication -- urgent reversal of ...
RAPS

Warfarin Patients Stand to Benefit from New FDA-Approved Drug Kcentra, Company Says

The US Food and Drug Administration (FDA) has approved Kcentra (prothrombin complex concentrate), a new biological treatment indicated for the urgent reversal of vitamin K antagonist (VKA), a class of ...
Medical Xpress

Kcentra approved to stop severe bleeding in heart patients

(HealthDay)—Kcentra (prothrombin complex concentrate, human) has been approved by the U.S. Food and Drug Administration to treat severe acute bleeding in adults after administration of the ...
Medindia

CSL Behring Receives FDA Approval of Kcentra™ for Urgent Warfarin Reversal in Patients with Acute Major Bleeding

Kcentra™ Is the First FDA-Approved 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in the U.S. CSL Behring announced today that the U.S. Food and Drug Administration (FDA) approved ...
Medscape

FDA okays Kcentra to reverse anticoagulation, stop bleeding

Silver Spring, MD - The US Food and Drug Administration (FDA) has approved a plasma-derived product for the urgent reversal of vitamin-K antagonist (VKA) anticoagulation in adults with acute major ...